Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What the stock price is telling us

<Some of us thought he was saying product revenue (red cherry piece of pie) would grow fast to make the pie chart transition. I think now we know he meant that MMP revenue (blue water piece) would evaporate fast.>

The current MMP revs are not representative of the past. We all know why. If we assume eventual recert by the USPTO w/o loss of teeth, why wouldn't you expect at least the historic MMP revenue levels, if not more? I'm having some difficulty following your pie logic, unless you are assuming the loss of most of the MMP in the reexam process. Is that your expectation?

Opty

Share
New Message
Please login to post a reply